Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: A randomised trial

Lancet

Volumn 353, Issue 9151, 1999, Pages 429-438

  Yusuf, Salim ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LEPIRUDIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; ST SEGMENT ELEVATION; STROKE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0033528281     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)07332-2     Document Type: Article

References (22)

1. Fuster V., Badimon L., Cohen M., Ambrose J.A., Badimon J.J., Cheseboro J.H. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 77:1988;1213-1220.
2. Collaborative overview of randomised trials of antiplatelet therapy-1: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 308:1994;81-106.
3. Yusuf S., Wittes J., Friedman L. Overview of results of randomized clinical trials in heart disease: unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA. 2601:1988;2259-2263.
4. Theroux P., Ouimet H., McCans J.et al. Aspirin, heparin or both to treat unstable angina. N Engl J Med. 319:1988;1105-1111.
5. Low-molecular weight heparin during instability in coronary artery disease. Lancet. 347:1996;561-568.
6. Weitz J.L., Hudoba M., Massel D., Maraganore J., Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest. 86:1990;385-391.
7. Heras M., Chesebro J.H., Webster M.W.I.et al. Hirudin, heparin, and placebo during deep arterial injury in the pig: the in vivo role of thrombin in platelet-mediated thrombosis. Circulation. 82:1990;1476-1484.
8. Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Circulation. 96:1997;769-777.
9. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:1959;719-748.
10. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med. 335:1996;775-782.
11. Antman E.M. Hirudin in acute myocardial infarction: Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Circulation. 94:1996;911-921.
12. Oler A., Whooley M.A., Oler J., Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: a meta-analysis. JAMA. 276:1996;811-815.
13. White H.D., Aylward P.E., Frey M.J.et al. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Circulation. 95:1997;2155-2161.
14. Serruys P.W., Herrman J.P., Simon R.et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty: Helvetica Investigators. N Engl J Med. 333:1995;757-763.
15. Cohen M., Demers C., Gurfinkel E.P.et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med. 337:1997;447-452.
16. Klein W., Buchwald A., Hillis S.E.et al. Comparison of low-molecular weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease: Fragmin in Unstable Coronary Artery disease study (FRIC). Circulation. 96:1997;61-68.
17. Eriksson B.I., Wille-Jørgensen P.et al. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med. 337:1998;1329-1335.
18. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med. 338:1998;1498-1505.
19. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction: Platelet Receptor Inhibition in Ischemic Syndrome Management Study. N Engl J Med. 338:1998;1488-1497.
20. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
21. Collins R., Peto R., Baigent C., Sleight P. Aspirin, heparin and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med. 336:1997;847-860.
22. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet. 348:1996;1329-1339.